Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
Cyclerion Therapeutics, Inc. (CYCN) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/13/2023 SC 13G Slate Path Capital LP reports a 16.5% stake in Cyclerion Therapeutics, Inc.
02/12/2021 SC 13G MFN Partners Management, LP reports a 7.2% stake in CYCLERION THERAPEUTICS, INC.
08/10/2020 SC 13G Slate Path Capital LP reports a 18.3% stake in Cyclerion Therapeutics, Inc.
02/14/2020 SC 13G American Endowment Foundation reports a 8.7% stake in Cyclerion Therapeutics Inc.
02/07/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2020 SC 13G Artal International S.C.A. reports a 6.8% stake in Cyclerion Therapeutics, Inc.
12/27/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/17/2019 SC 13G Camber Capital Management LLC reports a 5.7% stake in Cyclerion Therapeutics, Inc
04/11/2019 SC 13G MFN Partners Management, LP reports a 5.5% stake in CYCLERION THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy